bronchial asthma
Conditions
Interventions
case group:inhale ICS/LABA
control group:inhale ICS/LABA
Sponsors
the fifth affiliated hospital of Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
20 Years to 63 Years
Inclusion criteria
Inclusion criteria: The inclusion criteria of asthma patients are as follows: patients aged 18-65 years; patients with an asthma diagnosis for more than 1 year; patients whose most recent two follow-ups with ACQ score 70% of the predicted value; patients whose medication to achieve the current control is an inhaled corticosteroid/long-acting beta-agonist (ICS/LABA), with ICS at a low to moderate dose (equivalent to 200-800 µg/day of budesonide); and patients with no other airway or lung disorders.
Exclusion criteria
Exclusion criteria: 1. Patients with pregnancy; 2. immunocompromised patients; 3. Patients who can't temporally withdraw the antihistamines, beta blocker, or beta agonist drugs; 4. Patients with severe hepatic or renal dysfunction; 5. Patients with arrhythmias.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| spirometry parameters;airway impedance;airway impedence; | — |
Countries
China
Contacts
Public ContactZheng Xiaobin
the fifth affiliated hospital of Sun Yat-sen University
Outcome results
None listed